4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Shawn Tomasello Other companies: Cabaletta Bio, Inc. (Director · Since at least Jul 21, 2023); Kalaris Therapeutics, Inc. (Director · Mar 29, 2022 – Jun 6, 2024 · Past); Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 31, 2024 · Past); UroGen Pharma Ltd. (Director · Jun 7, 2021 – Jun 7, 2021 · Past); Tcr2 Therapeutics Inc (Director · Feb 3, 2021 – Jun 1, 2023 · Past) | Director · Since at least Dec 10, 2020 |
| August Moretti Other companies: Vivani Medical, Inc. (Member of the Board · Since at least Jun 24, 2026); Cibus, Inc. (Director · Since at least Nov 18, 2024); Depomed Inc (Chief Financial Officer & SVP · Jan 3, 2012 – Mar 31, 2018 · Past); Alexza Pharmaceuticals Inc (Former SVP, CFO, GC & Sec · Mar 8, 2006 – Dec 31, 2011 · Past) | Chief Financial Officer · Dec 10, 2020 – May 15, 2023 · Past |
| Susannah Gray Other companies: AnaptysBio, Inc. (Director · Since at least Mar 26, 2026); Maravai LifeSciences Holdings, Inc. (Director · Since at least May 23, 2024); Theravance Biopharma, Inc. (Director · Since at least May 8, 2024); Morphic Holding Inc (Director · Jun 4, 2024 – Aug 16, 2024 · Past) | Director · Since at least May 21, 2024 |
| John F. Milligan Other companies: Kailera Therapeutics, Inc. (Board Chair · Since at least Apr 16, 2026); Pacific Biosciences of California, Inc. (Chairman of the Board · Since at least Jul 17, 2013); Gilead Sciences, Inc. (President and CEO, Director · Nov 7, 2013 – Nov 27, 2018 · Past) | Executive Chairman · Since at least Dec 10, 2020 |
| Kristian Humer Other companies: Foghorn Therapeutics Inc. (Chief Financial Officer · Since at least Apr 16, 2024); Sensei Biotherapeutics, Inc. (Director · Jul 30, 2021 – May 21, 2025 · Past); Viridian Therapeutics, Inc. (CFO and CBO · Jul 26, 2021 – Feb 8, 2023 · Past) | Chief Financial Officer · Since at least Dec 9, 2025 |
| Nancy Miller-Rich Other companies: Aldeyra Therapeutics, Inc. (Director · Since at least Jan 13, 2020); Kadmon Holdings Inc (Director · Aug 13, 2020 – Nov 9, 2021 · Past); Intercept Pharmaceuticals Inc (Director · Apr 24, 2018 – Nov 8, 2023 · Past) | Director · Since at least Dec 10, 2020 |
| Glenn P. Sblendorio Other companies: Mineralys Therapeutics, Inc. (Chairman · Since at least Feb 19, 2026); Amicus Therapeutics Inc (Director · Since at least Jun 5, 2025) | Board Member · Since at least Jan 5, 2026 |
| Uneek Mehra Other companies: BridgeBio Oncology Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 11, 2025); Myovant Sciences Ltd (Principal Financial Officer · Sep 7, 2021 – Mar 10, 2023 · Past) | See Remarks · Sep 22, 2023 – Mar 6, 2025 · Past |
| Charles Theuer Other companies: Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past) | Director · Since at least Dec 10, 2020 |
| Christopher Paul Simms Other companies: IVERIC bio Inc (SVP, Chief Commercial Officer · Aug 2, 2021 – Jul 11, 2023 · Past) | See Remarks · Since at least Dec 9, 2025 |
| David Schaffer Other companies: uniQure N.V. (Director · Jan 1, 2017 – Feb 27, 2020 · Past) | Director · Dec 10, 2020 – Oct 20, 2021 · Past |
| Jacob Chacko Other companies: ORIC Pharmaceuticals, Inc. (PRESIDENT AND CEO, Director · Since at least Feb 1, 2021) | Director · Since at least Dec 10, 2020 |
| Ashoo Gupta | VP, Finance and Controller · Since at least Sep 30, 2025 |
| Carolyne Zimmermann | Chief Business Officer · Jun 7, 2021 – Feb 1, 2022 · Past |
| Chris Simms | Chief Commercial & Business Officer · Since at least Mar 18, 2026 |
| David Kirn | Chief Executive Officer, President, and Co-Founder · Since at least Dec 10, 2020 |
| Dhaval Desai | Chief Development Officer · Since at least Sep 2, 2025 |
| Fariborz Kamal | President & COO · Dec 10, 2020 – Mar 6, 2025 · Past |
| Julie Clark | Chief Medical Officer · Since at least Jun 29, 2026 |
| Katy Barglow | Chief Technical Officer · Since at least Mar 18, 2026 |
| Kim Maplestone | Chief Clinical Operations Officer · Since at least Mar 18, 2026 |
| Noriyuki Kasahara | Director · Sep 23, 2022 – May 23, 2023 · Past |
| Robert Young Kim | Chief Medical Officer · Mar 24, 2023 – Mar 6, 2025 · Past |
| Scott Bizily | Chief Legal Officer · Since at least Mar 21, 2022 |
| Theresa Janke | Chief of Staff, Co-Founder · Since at least Nov 4, 2026 |